Loading…

Amplification of pulsatile glucagon counterregulation by switch-off of alpha-cell-suppressing signals in streptozotocin-treated rats

Glucagon counterregulation (GCR) is a key protection against hypoglycemia that is compromised in diabetes via an unknown mechanism. To test the hypothesis that alpha-cell-inhibiting signals that are switched off during hypoglycemia amplify GCR, we studied streptozotocin (STZ)-treated male Wistar rat...

Full description

Saved in:
Bibliographic Details
Published in:American journal of physiology: endocrinology and metabolism 2008-09, Vol.295 (3), p.E575-E585
Main Authors: Farhy, Leon S, Du, Zhongmin, Zeng, Qiang, Veldhuis, Paula P, Johnson, Michael L, Brayman, Kenneth L, McCall, Anthony L
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c400t-92516a3526810ac1ad4a6cfdcff43d50170c5202f74c68de33d85f979498209f3
cites cdi_FETCH-LOGICAL-c400t-92516a3526810ac1ad4a6cfdcff43d50170c5202f74c68de33d85f979498209f3
container_end_page E585
container_issue 3
container_start_page E575
container_title American journal of physiology: endocrinology and metabolism
container_volume 295
creator Farhy, Leon S
Du, Zhongmin
Zeng, Qiang
Veldhuis, Paula P
Johnson, Michael L
Brayman, Kenneth L
McCall, Anthony L
description Glucagon counterregulation (GCR) is a key protection against hypoglycemia that is compromised in diabetes via an unknown mechanism. To test the hypothesis that alpha-cell-inhibiting signals that are switched off during hypoglycemia amplify GCR, we studied streptozotocin (STZ)-treated male Wistar rats and estimated the effect on GCR of intrapancreatic infusion and termination during hypoglycemia of saline, insulin, and somatostatin. Times 10 min before and 45 min after the switch-off were analyzed. Insulin and somatostatin, but not saline, switch-off significantly increased the glucagon levels (P = 0.03), and the fold increases relative to baseline were significantly higher (P < 0.05) in the insulin and somatostatin groups vs. the saline group. The peak concentrations were also higher in the insulin (368 pg/ml) and somatostatin (228 pg/ml) groups vs. the saline (114 pg/ml) group (P < 0.05). GCR was pulsatile in most animals, indicating a feedback regulation. After the switch-off, the number of secretory events and the total pulsatile production were lower in the saline group vs. the insulin and somatostatin groups (P < 0.05), indicating enhancement of glucagon pulsatile activity by insulin and somatostatin compared with saline. Network modeling analysis demonstrates that reciprocal interactions between alpha- and delta-cells can explain the amplification by interpreting the GCR as a rebound response to the switch-off. The model justifies experimental designs to further study the intrapancreatic network in relation to the switch-off phenomenon. The results of this proof-of-concept interdisciplinary study support the hypothesis that GCR develops as a rebound pulsatile response of the intrapancreatic endocrine feedback network to switch-off of alpha-cell-inhibiting islet signals.
doi_str_mv 10.1152/ajpendo.90372.2008
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2536740</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18577688</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-92516a3526810ac1ad4a6cfdcff43d50170c5202f74c68de33d85f979498209f3</originalsourceid><addsrcrecordid>eNpVkc1OHDEQhK0oKCyQF8ghmhfw0rbHM55LJITCj4TEJTlbxmPPGnlty_YQkTMPzmx2FeDUqu6q6sOH0DcCa0I4PVePyYQxrgdgPV1TAPEJrZYDxYRz_hmtgAwME9EOx-iklEcA6HlLv6BjInjfd0Ks0MvFNnlnnVbVxdBE26TZl0V400x-1mpatjrOoZqczTT7ve_huSl_XNUbHK3dpZRPG4W18R6XOaVsSnFhaoqbgvKlcaEpNZtU499Yo3YBL0pVMzZZ1XKGjuziMl8P8xT9vvr56_IG391f315e3GHdAlQ8UE46xTjtBAGliRpb1Wk7amtbNnIgPWhOgdq-1Z0YDWOj4Hboh3YQFAbLTtGPfW-aH7Zm1CbUrLxM2W1VfpZROfnxEtxGTvFJUs66voWlgO4LdI6lZGP_ZwnIHRN5YCL_MZE7Jkvo-_uvb5EDBPYK02uPUw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Amplification of pulsatile glucagon counterregulation by switch-off of alpha-cell-suppressing signals in streptozotocin-treated rats</title><source>American Physiological Society Free</source><creator>Farhy, Leon S ; Du, Zhongmin ; Zeng, Qiang ; Veldhuis, Paula P ; Johnson, Michael L ; Brayman, Kenneth L ; McCall, Anthony L</creator><creatorcontrib>Farhy, Leon S ; Du, Zhongmin ; Zeng, Qiang ; Veldhuis, Paula P ; Johnson, Michael L ; Brayman, Kenneth L ; McCall, Anthony L</creatorcontrib><description>Glucagon counterregulation (GCR) is a key protection against hypoglycemia that is compromised in diabetes via an unknown mechanism. To test the hypothesis that alpha-cell-inhibiting signals that are switched off during hypoglycemia amplify GCR, we studied streptozotocin (STZ)-treated male Wistar rats and estimated the effect on GCR of intrapancreatic infusion and termination during hypoglycemia of saline, insulin, and somatostatin. Times 10 min before and 45 min after the switch-off were analyzed. Insulin and somatostatin, but not saline, switch-off significantly increased the glucagon levels (P = 0.03), and the fold increases relative to baseline were significantly higher (P &lt; 0.05) in the insulin and somatostatin groups vs. the saline group. The peak concentrations were also higher in the insulin (368 pg/ml) and somatostatin (228 pg/ml) groups vs. the saline (114 pg/ml) group (P &lt; 0.05). GCR was pulsatile in most animals, indicating a feedback regulation. After the switch-off, the number of secretory events and the total pulsatile production were lower in the saline group vs. the insulin and somatostatin groups (P &lt; 0.05), indicating enhancement of glucagon pulsatile activity by insulin and somatostatin compared with saline. Network modeling analysis demonstrates that reciprocal interactions between alpha- and delta-cells can explain the amplification by interpreting the GCR as a rebound response to the switch-off. The model justifies experimental designs to further study the intrapancreatic network in relation to the switch-off phenomenon. The results of this proof-of-concept interdisciplinary study support the hypothesis that GCR develops as a rebound pulsatile response of the intrapancreatic endocrine feedback network to switch-off of alpha-cell-inhibiting islet signals.</description><identifier>ISSN: 0193-1849</identifier><identifier>EISSN: 1522-1555</identifier><identifier>DOI: 10.1152/ajpendo.90372.2008</identifier><identifier>PMID: 18577688</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Algorithms ; Animals ; Blood Glucose - physiology ; Data Interpretation, Statistical ; Diabetes Mellitus, Experimental - metabolism ; Diabetes Mellitus, Experimental - physiopathology ; Feedback, Physiological ; Glucagon - metabolism ; Glucagon - physiology ; Glucagon-Secreting Cells - drug effects ; Glucagon-Secreting Cells - physiology ; Half-Life ; Hormone Antagonists - pharmacology ; Insulin-Secreting Cells - drug effects ; Insulin-Secreting Cells - physiology ; Male ; Models, Statistical ; Rats ; Rats, Wistar ; Signal Transduction - drug effects ; Signal Transduction - physiology ; Somatostatin - pharmacology</subject><ispartof>American journal of physiology: endocrinology and metabolism, 2008-09, Vol.295 (3), p.E575-E585</ispartof><rights>Copyright © 2008, American Physiological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-92516a3526810ac1ad4a6cfdcff43d50170c5202f74c68de33d85f979498209f3</citedby><cites>FETCH-LOGICAL-c400t-92516a3526810ac1ad4a6cfdcff43d50170c5202f74c68de33d85f979498209f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18577688$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Farhy, Leon S</creatorcontrib><creatorcontrib>Du, Zhongmin</creatorcontrib><creatorcontrib>Zeng, Qiang</creatorcontrib><creatorcontrib>Veldhuis, Paula P</creatorcontrib><creatorcontrib>Johnson, Michael L</creatorcontrib><creatorcontrib>Brayman, Kenneth L</creatorcontrib><creatorcontrib>McCall, Anthony L</creatorcontrib><title>Amplification of pulsatile glucagon counterregulation by switch-off of alpha-cell-suppressing signals in streptozotocin-treated rats</title><title>American journal of physiology: endocrinology and metabolism</title><addtitle>Am J Physiol Endocrinol Metab</addtitle><description>Glucagon counterregulation (GCR) is a key protection against hypoglycemia that is compromised in diabetes via an unknown mechanism. To test the hypothesis that alpha-cell-inhibiting signals that are switched off during hypoglycemia amplify GCR, we studied streptozotocin (STZ)-treated male Wistar rats and estimated the effect on GCR of intrapancreatic infusion and termination during hypoglycemia of saline, insulin, and somatostatin. Times 10 min before and 45 min after the switch-off were analyzed. Insulin and somatostatin, but not saline, switch-off significantly increased the glucagon levels (P = 0.03), and the fold increases relative to baseline were significantly higher (P &lt; 0.05) in the insulin and somatostatin groups vs. the saline group. The peak concentrations were also higher in the insulin (368 pg/ml) and somatostatin (228 pg/ml) groups vs. the saline (114 pg/ml) group (P &lt; 0.05). GCR was pulsatile in most animals, indicating a feedback regulation. After the switch-off, the number of secretory events and the total pulsatile production were lower in the saline group vs. the insulin and somatostatin groups (P &lt; 0.05), indicating enhancement of glucagon pulsatile activity by insulin and somatostatin compared with saline. Network modeling analysis demonstrates that reciprocal interactions between alpha- and delta-cells can explain the amplification by interpreting the GCR as a rebound response to the switch-off. The model justifies experimental designs to further study the intrapancreatic network in relation to the switch-off phenomenon. The results of this proof-of-concept interdisciplinary study support the hypothesis that GCR develops as a rebound pulsatile response of the intrapancreatic endocrine feedback network to switch-off of alpha-cell-inhibiting islet signals.</description><subject>Algorithms</subject><subject>Animals</subject><subject>Blood Glucose - physiology</subject><subject>Data Interpretation, Statistical</subject><subject>Diabetes Mellitus, Experimental - metabolism</subject><subject>Diabetes Mellitus, Experimental - physiopathology</subject><subject>Feedback, Physiological</subject><subject>Glucagon - metabolism</subject><subject>Glucagon - physiology</subject><subject>Glucagon-Secreting Cells - drug effects</subject><subject>Glucagon-Secreting Cells - physiology</subject><subject>Half-Life</subject><subject>Hormone Antagonists - pharmacology</subject><subject>Insulin-Secreting Cells - drug effects</subject><subject>Insulin-Secreting Cells - physiology</subject><subject>Male</subject><subject>Models, Statistical</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Signal Transduction - drug effects</subject><subject>Signal Transduction - physiology</subject><subject>Somatostatin - pharmacology</subject><issn>0193-1849</issn><issn>1522-1555</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNpVkc1OHDEQhK0oKCyQF8ghmhfw0rbHM55LJITCj4TEJTlbxmPPGnlty_YQkTMPzmx2FeDUqu6q6sOH0DcCa0I4PVePyYQxrgdgPV1TAPEJrZYDxYRz_hmtgAwME9EOx-iklEcA6HlLv6BjInjfd0Ks0MvFNnlnnVbVxdBE26TZl0V400x-1mpatjrOoZqczTT7ve_huSl_XNUbHK3dpZRPG4W18R6XOaVsSnFhaoqbgvKlcaEpNZtU499Yo3YBL0pVMzZZ1XKGjuziMl8P8xT9vvr56_IG391f315e3GHdAlQ8UE46xTjtBAGliRpb1Wk7amtbNnIgPWhOgdq-1Z0YDWOj4Hboh3YQFAbLTtGPfW-aH7Zm1CbUrLxM2W1VfpZROfnxEtxGTvFJUs66voWlgO4LdI6lZGP_ZwnIHRN5YCL_MZE7Jkvo-_uvb5EDBPYK02uPUw</recordid><startdate>20080901</startdate><enddate>20080901</enddate><creator>Farhy, Leon S</creator><creator>Du, Zhongmin</creator><creator>Zeng, Qiang</creator><creator>Veldhuis, Paula P</creator><creator>Johnson, Michael L</creator><creator>Brayman, Kenneth L</creator><creator>McCall, Anthony L</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20080901</creationdate><title>Amplification of pulsatile glucagon counterregulation by switch-off of alpha-cell-suppressing signals in streptozotocin-treated rats</title><author>Farhy, Leon S ; Du, Zhongmin ; Zeng, Qiang ; Veldhuis, Paula P ; Johnson, Michael L ; Brayman, Kenneth L ; McCall, Anthony L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-92516a3526810ac1ad4a6cfdcff43d50170c5202f74c68de33d85f979498209f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Algorithms</topic><topic>Animals</topic><topic>Blood Glucose - physiology</topic><topic>Data Interpretation, Statistical</topic><topic>Diabetes Mellitus, Experimental - metabolism</topic><topic>Diabetes Mellitus, Experimental - physiopathology</topic><topic>Feedback, Physiological</topic><topic>Glucagon - metabolism</topic><topic>Glucagon - physiology</topic><topic>Glucagon-Secreting Cells - drug effects</topic><topic>Glucagon-Secreting Cells - physiology</topic><topic>Half-Life</topic><topic>Hormone Antagonists - pharmacology</topic><topic>Insulin-Secreting Cells - drug effects</topic><topic>Insulin-Secreting Cells - physiology</topic><topic>Male</topic><topic>Models, Statistical</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Signal Transduction - drug effects</topic><topic>Signal Transduction - physiology</topic><topic>Somatostatin - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Farhy, Leon S</creatorcontrib><creatorcontrib>Du, Zhongmin</creatorcontrib><creatorcontrib>Zeng, Qiang</creatorcontrib><creatorcontrib>Veldhuis, Paula P</creatorcontrib><creatorcontrib>Johnson, Michael L</creatorcontrib><creatorcontrib>Brayman, Kenneth L</creatorcontrib><creatorcontrib>McCall, Anthony L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of physiology: endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Farhy, Leon S</au><au>Du, Zhongmin</au><au>Zeng, Qiang</au><au>Veldhuis, Paula P</au><au>Johnson, Michael L</au><au>Brayman, Kenneth L</au><au>McCall, Anthony L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amplification of pulsatile glucagon counterregulation by switch-off of alpha-cell-suppressing signals in streptozotocin-treated rats</atitle><jtitle>American journal of physiology: endocrinology and metabolism</jtitle><addtitle>Am J Physiol Endocrinol Metab</addtitle><date>2008-09-01</date><risdate>2008</risdate><volume>295</volume><issue>3</issue><spage>E575</spage><epage>E585</epage><pages>E575-E585</pages><issn>0193-1849</issn><eissn>1522-1555</eissn><abstract>Glucagon counterregulation (GCR) is a key protection against hypoglycemia that is compromised in diabetes via an unknown mechanism. To test the hypothesis that alpha-cell-inhibiting signals that are switched off during hypoglycemia amplify GCR, we studied streptozotocin (STZ)-treated male Wistar rats and estimated the effect on GCR of intrapancreatic infusion and termination during hypoglycemia of saline, insulin, and somatostatin. Times 10 min before and 45 min after the switch-off were analyzed. Insulin and somatostatin, but not saline, switch-off significantly increased the glucagon levels (P = 0.03), and the fold increases relative to baseline were significantly higher (P &lt; 0.05) in the insulin and somatostatin groups vs. the saline group. The peak concentrations were also higher in the insulin (368 pg/ml) and somatostatin (228 pg/ml) groups vs. the saline (114 pg/ml) group (P &lt; 0.05). GCR was pulsatile in most animals, indicating a feedback regulation. After the switch-off, the number of secretory events and the total pulsatile production were lower in the saline group vs. the insulin and somatostatin groups (P &lt; 0.05), indicating enhancement of glucagon pulsatile activity by insulin and somatostatin compared with saline. Network modeling analysis demonstrates that reciprocal interactions between alpha- and delta-cells can explain the amplification by interpreting the GCR as a rebound response to the switch-off. The model justifies experimental designs to further study the intrapancreatic network in relation to the switch-off phenomenon. The results of this proof-of-concept interdisciplinary study support the hypothesis that GCR develops as a rebound pulsatile response of the intrapancreatic endocrine feedback network to switch-off of alpha-cell-inhibiting islet signals.</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>18577688</pmid><doi>10.1152/ajpendo.90372.2008</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0193-1849
ispartof American journal of physiology: endocrinology and metabolism, 2008-09, Vol.295 (3), p.E575-E585
issn 0193-1849
1522-1555
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2536740
source American Physiological Society Free
subjects Algorithms
Animals
Blood Glucose - physiology
Data Interpretation, Statistical
Diabetes Mellitus, Experimental - metabolism
Diabetes Mellitus, Experimental - physiopathology
Feedback, Physiological
Glucagon - metabolism
Glucagon - physiology
Glucagon-Secreting Cells - drug effects
Glucagon-Secreting Cells - physiology
Half-Life
Hormone Antagonists - pharmacology
Insulin-Secreting Cells - drug effects
Insulin-Secreting Cells - physiology
Male
Models, Statistical
Rats
Rats, Wistar
Signal Transduction - drug effects
Signal Transduction - physiology
Somatostatin - pharmacology
title Amplification of pulsatile glucagon counterregulation by switch-off of alpha-cell-suppressing signals in streptozotocin-treated rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T09%3A08%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amplification%20of%20pulsatile%20glucagon%20counterregulation%20by%20switch-off%20of%20alpha-cell-suppressing%20signals%20in%20streptozotocin-treated%20rats&rft.jtitle=American%20journal%20of%20physiology:%20endocrinology%20and%20metabolism&rft.au=Farhy,%20Leon%20S&rft.date=2008-09-01&rft.volume=295&rft.issue=3&rft.spage=E575&rft.epage=E585&rft.pages=E575-E585&rft.issn=0193-1849&rft.eissn=1522-1555&rft_id=info:doi/10.1152/ajpendo.90372.2008&rft_dat=%3Cpubmed_cross%3E18577688%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c400t-92516a3526810ac1ad4a6cfdcff43d50170c5202f74c68de33d85f979498209f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/18577688&rfr_iscdi=true